Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 4, Issue 9

1 September 1998

Front Matter
Table of Contents
Back Matter
Editorial Board

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Hypothesis
Advances in Brief
Research Articles

Hypothesis

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.

E Frei, 3rd; A Elias; C Wheeler; P Richardson; W Hryniuk

Advances in Brief

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.

R Fety; F Rolland; M Barberi-Heyob; A Hardouin; L Campion; T Conroy; J L Merlin; A Rivière; G Perrocheau; M C Etienne; G Milano

Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.

S Schulz; J Schmitt; D Wiborny; H Schmidt; S Olbricht; W Weise; A Roessner; C Gramsch; V Höllt

Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.

H Shinohara; J J Killion; H Kuniyasu; R Kumar; I J Fidler

Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.

D Siegel; W A Franklin; D Ross

The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.

M L Hauck; M R Zalutsky

Research Articles

Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.

P H Walz; P Björk; P O Gunnarsson; K Edman; B Hartley-Asp

Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.

D H Ho; R Pazdur; W Covington; N Brown; Y Y Huo; Y Lassere; J Kuritani

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

J Geisler; N King; G Anker; G Ornati; E Di Salle; P E Lønning; M Dowsett

Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.

V K Kasturi; M P Dearing; S C Piscitelli; E K Russell; G G Sladek; K O'Neil; G A Turner; T L Morton; M C Christian; B E Johnson; M J Kelley

Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.

M A Steller; K J Gurski; M Murakami; R W Daniel; K V Shah; E Celis; A Sette; E L Trimble; R C Park; F M Marincola

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.

S R Alberts; C Erlichman; J M Reid; J A Sloan; M M Ames; R L Richardson; R M Goldberg

Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.

D P Wood, Jr; A Beaman; M Banerjee; I Powell; E Pontes; M L Cher

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.

J Geisler; S B Geisler; P E Lønning; R Smaaland; K M Tveit; H Refsum; P M Ueland

Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer.

Y Maehara; S Hasuda; T Abe; E Oki; Y Kakeji; S Ohno; K Sugimachi

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.

K Kramer; W L Gerald; B H Kushner; S M Larson; M Hameed; N K Cheung

Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.

Y Ko; M Klinz; G Totzke; I Gouni-Berthold; A Sachinidis; H Vetter

Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.

R Ralhan; N Nath; S Agarwal; M Mathur; B Wasylyk; N K Shukla

Specific transcription factors prognostic for prostate cancer progression.

K Aoyagi; I Shima; M Wang; Y Hu; F U Garcia; M E Stearns

Angiogenin expression and prognosis in primary breast carcinoma.

S Montero; C Guzmán; H Cortés-Funes; R Colomer

Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.

L Zhang; J W Taub; M Williamson; S C Wong; B Hukku; J Pullen; Y Ravindranath; L H Matherly

Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.

C Caenazzo; M Onisto; L Sartor; R Scalerta; A Giraldo; D Nitti; S Garbisa

Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.

T Tsurusaki; T Koji; H Sakai; H Kanetake; Y Saito

Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas.

Y Kitadai; K Haruma; T Tokutomi; S Tanaka; K Sumii; M Carvalho; M Kuwabara; K Yoshida; T Hirai; G Kajiyama; E Tahara

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.

C T Hsueh; D Kelsen; G K Schwartz

Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.

A E Frimberger; A S Moore; L Cincotta; S M Cotter; J W Foley

Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.

W E Carson

Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.

J Ju; S E Kane; H J Lenz; K D Danenberg; E Chu; P V Danenberg

Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.

C Russoniello; C Somasundaram; J Schlom; Y M Deo; T Keler

Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.

S P Langdon; H Gabra; J M Bartlett; G J Rabiaz; R A Hawkins; A L Tesdale; A A Ritchie; W R Miller; J F Smyth

Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice.

C L Wilkerson; S R Darjatmoko; M J Lindstrom; D M Albert

Antimestatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones: Orthotopic growth in severe combined immunodeficient mice.

M E Stearns; M Wang

Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.

D K Frank; T J Liu; M J Frederick; G L Clayman

Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.

Y Oda; A Sakamoto; N Shinohara; T Ohga; T Uchiumi; K Kohno; M Tsuneyoshi; M Kuwano; Y Iwamoto

Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung.

S R Wright; A H Boag; G Valdimarsson; D R Hipfner; B G Campling; S P Cole; R G Deeley

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

Data-Rich Spatial Profiling of Cancer Tissue: Astronomy Informs Pathology

All About That Ras: Novel Fusion Drives Ras Pathway Activation in Lung Cancer

CUB domain containing protein 1 (CDCP1) is a target for radioligand therapy in castration resistant prostate cancer including PSMA null disease

Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept